BioCentury
ARTICLE | Clinical News

Enterotoxigenic E: Phase I trial

November 2, 1998 8:00 AM UTC

Peptide Therapeutics Group plc (LSE:PTE), Cambridge, U.K. Product: Enterotoxigenic E. coli (ETEC) live attenuated vaccine Indication: Treat travelers' diarrhea Status: PTE initiated a dose-ranging U....